HOME >> BIOLOGY >> NEWS
Enzyme family plays role in Alzheimer's: University of Toronto study

The route to a treatment for Alzheimer's disease may have become more straightforward with the discovery that a key enzyme known to have a major role in this disease is in fact part of a family of enzymes. Only some family members play a role in the progression of this brain-wasting illness, new research at the University of Toronto has found.

"It was previously thought that an enzyme called gamma-secretase contributed to the development of protein deposits in the Alzheimer's brain. This study shows that this enzyme is more accurately described as a family of enzymes, each with its own specialization," explains Professor David Westaway of U of T's Centre for Research in Neurodegenerative Diseases and senior author of a paper in the June 21 issue of the Proceedings of the National Academy of Sciences.

Gamma-secretase enzymes generate toxic molecules called amyloid-beta peptides. These peptides produce deposits called amyloid plaques, the brain lesions that are a defining feature of Alzheimer's disease. If scientists can stop these enzymes from working, they will be able to stop their resulting toxic molecules from forming in the brain. Complicating the situation is the fact that the gamma-secretase enzyme was also thought to be involved in healthy functioning of other tissues; therefore, therapies would have to inhibit the negative effects while maintaining the normal functioning of other cells.

Westaway and his research colleagues used genetically-engineered mice to show that toxic activity of gamma-secretase could be separated from its other benign activities.

"This finding provides hope that Alzheimer's treatments can be developed that reduces toxic activity of certain gamma-secretases while still maintaining the beneficial activities of other family members," says Peter Mastrangelo, a research associate in Westaway's lab and first author of the paper.


'"/>

Contact: Janet Wong
jf.wong@utoronto.ca
416-978-5949
University of Toronto
20-Jun-2005


Page: 1

Related biology news :

1. Enzyme discovery sheds light on vitamin D
2. Enzyme delivered in smaller package protects cells from radiation damage
3. Enzyme Engineering XIX
4. Enzyme inhibitor produces stable disease in patients with advanced solid cell cancers
5. Enzyme shreds Alzheimers protein
6. Enzyme defect leads to hyperinsulinism
7. Eat less, weigh more? Enzyme makes lean mice susceptible to dietary fat
8. Enzyme crystal structure reveals unexpected genome repair functions
9. Enzyme inhibitors block replication of SARS virus
10. Enzyme may be target for new anti-inflammatory compounds
11. Enzyme action creates protein linked to Alzheimers disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/2/2018)... ... October 02, 2018 , ... Stuart is a fun-loving eight-year-old Labrador retriever. Like many labs, ... Cynthia, “He loves playing ball so much that whenever anyone comes to our door, he ... game of fetch.” In early 2017, Stuart began limping and eventually could no longer ...
(Date:10/2/2018)... ... 2018 , ... The Federal Identity Forum & Exposition (FedID ... The Palo Alto-based face recognition company, Camvi Technologies Inc., was invited to speak ... U.S. Federal executives from Department of Defense (DoD) and Federal Bureau of Investigation ...
(Date:10/1/2018)... ... October 01, 2018 , ... NanoValent Pharmaceuticals, Inc ., ... based therapeutics, today announced the National Institute of Health (NIH) ... year funding for two separate grants. These two grants will allow NanoValent to ...
Breaking Biology News(10 mins):
(Date:9/27/2018)... ... September 26, 2018 , ... Consumers ... of their primary care physicians, according to a new Zeldis Research and Schlesinger ... doctors were asked about consumer adoption of fitness and health wearables, remote monitoring, ...
(Date:9/27/2018)... ... 2018 , ... Nvision Biomedical Technologies , a San ... at the North American Spine Society (NASS) Annual Meeting, held at the Los ... System, which received clearance from the U.S. Food and Drug Administration (FDA) in ...
(Date:9/27/2018)... ... September 27, 2018 , ... ... MA, announce today that Holotype HLA and other Omixon products will be featured ... the American Society for Histocompatibility and Immunogenetics (ASHI) in Baltimore, MD. Additionally, Omixon’s ...
(Date:9/22/2018)... ... September 20, 2018 , ... ... a strategic venture. The synergistic combination of Predicine’s GeneRADAR molecular insights platform ... biomarker profiling to empower clinical trials in the immuno-oncology (IO) space. , ...
Breaking Biology Technology:
Cached News: